SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-156150
Filing Date
2022-05-20
Accepted
2022-05-20 16:13:37
Documents
6
Effectiveness Date
2022-05-20

Document Format Files

Seq Description Document Type Size
1 S-8 d345411ds8.htm S-8 56065
2 EX-5.1 d345411dex51.htm EX-5.1 6579
3 EX-23.1 d345411dex231.htm EX-23.1 1660
4 EX-99.1 d345411dex991.htm EX-99.1 278591
5 EX-FILING FEES d345411dexfilingfees.htm EX-FILING FEES 15136
6 GRAPHIC g345411g82s63.jpg GRAPHIC 3052
  Complete submission text file 0001193125-22-156150.txt   363340
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265112 | Film No.: 22947739
SIC: 2834 Pharmaceutical Preparations